The tech scene known for biotech and robotics is living up to its reputation. Boston tech innovators in these sectors and more made new growth moves last week. Catch up on the latest with the Built In Boston Weekly Refresh.
Ledgebrook pulled in $4.6M. Working to expedite the quoting experience for wholesale brokers, Ledgebrook plans to enhance its solution that combines tech and expert underwriting. The insurtech company recently announced a new round of funding to scale its platform and develop more offerings. Investor Markd led the round. [PR Newswire]
Veo Robotics secured new funding. Backed by Amazon Industrial Innovation Fund, Veo Robotics announced a new round of capital that brings its total raised to $29 million. The company will invest in business partnerships to build human-inclusive robotic solutions that leverage Veo’s safety technology. [Tech Funding News]
Boston Tech Quote of the Week
“In recent years, we have only just started to see the expansive potential RNA-based therapeutics may offer to the future of medicine and how we treat disease. Since our founding, we have been diligently focused on advancing our platform of RNA technologies to elucidate the most promising opportunities with our initial programs so we may reach patients as efficiently as possible.” — Giuseppe Ciaramella, Orbital co-founder and CEO
Orbital Therapeutics raised $270M. Based in Cambridge, Orbital Therapeutics works to expand the applicability of RNA-based medicines across various human diseases in areas like vaccines, immunomodulation and protein replacement. The company pulled in Series A funding led by ARCH Venture Partners to further its tech and announced the addition of a new chief operating officer and chief financial officer to its leadership team. [Business Wire]
Tripleseat to sell a majority stake. Tripleseat is an events management platform based in Concord. The company develops event planning software for businesses in the hospitality industry, such as restaurants and hotels. Shareholder General Atlantic plans to buy a majority stake in the company, bringing Tripleseat’s valuation to $500 million. [Reuters]
Formlabs hired a new CRO. Specializing in 3D printing technology, Formlabs announced the appointment of Nick Graham as its new chief revenue officer. Graham was previously the CRO at EverQuote and will now work to help Formlabs grow its revenue and expand its customer base. [Built In Boston]
